ConductScience.org, home

Paper12925844

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

Edinger M and 6 others. Nat Med, 2003. Cited by 1,074 papers, by iCite.

Cite this record

ConductScience Library. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Papers, record 12925844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12925844

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
PubMed
Journal
Nat Med
PubMed
Year
2003
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,074
iCite
Relative citation ratio, by iCite
19.7
iCite
Revised in PubMed
2022-03-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Edinger MMatthias
2Hoffmann PPetra
3Ermann JJoerg
4Drago KKathryn
5Fathman CGC Garrison
6Strober SSamuel
7Negrin RSRobert S

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow TransplantationMajor topic
Graft vs Host DiseaseMajor topic
T-LymphocytesMajor topic
Animals
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Survival
Female
Interferon-gamma
Interleukin-2 Receptor alpha Subunit
Leukemia
Lymphoma
Membrane Glycoproteins
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Mutant Strains
Perforin
Pore Forming Cytotoxic Proteins
Receptors, Interleukin
Receptors, Interleukin-2
Transplantation, Homologous

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI49903NIAID NIH HHSUnited StatesR21AI049903PubMed and NIHNIH RePORTER
CA65237NCI NIH HHSUnited StatesR01CA065237PubMed and NIHNIH RePORTER
CA92225NCI NIH HHSUnited StatesR01CA092225PubMed and NIHNIH RePORTER
DK61925NIDDK NIH HHSUnited StatesU01DK061925PubMed and NIHNIH RePORTER
HL57443NHLBI NIH HHSUnited StatesP01HL057443PubMed and NIHNIH RePORTER
HL58520NHLBI NIH HHSUnited StatesR29HL058520PubMed and NIHNIH RePORTER
P01-CA49605NCI NIH HHSUnited StatesP01CA049605PubMed and NIHNIH RePORTER
R01S CA8006NCI NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01244906Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) TransplantBackgroundClinicalTrials.gov
NCT06845592
Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia
BackgroundClinicalTrials.gov
NCT07576699CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)BackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in12949524Taming transplantation with T cells.https://conductscience.org/library/papers/12949524

Source PubMed

Download CSV of comments and corrections

Cited by605

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,074 citations.

PMIDTitleJournalYearIn PapersSource
42913002NAD+ metabolic restoration resolves the inflammation-immunocompetence trade-off in lung graft-versus-host disease.Sci Adv2026https://conductscience.org/library/papers/42913002PubMed
42851423Short term ex vivo graft conditioning with venetoclax, fluticasone propionate, and IL-2 reduces graft versus host disease in mouse allogeneic hematopoietic cell transplantation.Front Immunol2026https://conductscience.org/library/papers/42851423PubMed
42617044CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GVL while limiting GVHD after HSCT.Blood Adv2026https://conductscience.org/library/papers/42617044PubMed
42495148Acute gastrointestinal graft-versus-host disease is associated with reductions of secondary bile acids following allogeneic hematopoietic cell transplantation.Front Microbiol2026https://conductscience.org/library/papers/42495148PubMed
42277051Chronic graft-versus-host disease.Nat Rev Dis Primers2026https://conductscience.org/library/papers/42277051PubMed
42274698Mapping Therapeutic Regulatory T Cell Fate with MRI: Current Strategies and Translational Outlook.Nanomaterials (Basel)2026https://conductscience.org/library/papers/42274698PubMed
42193279
Lineage-Specific Chimerism Analysis After Allogeneic Hematopoietic Cell Transplantation in Patients with Myeloid Neoplasms: Current Evidence and Considerations in the Post-Transplant Cyclophosphamide Setting.
Biomedicines2026https://conductscience.org/library/papers/42193279PubMed
42122228Myeloid Cell-Targeting PLGA Nanoparticles Ameliorate Acute Graft-Versus-Host Disease.Cancers (Basel)2026https://conductscience.org/library/papers/42122228PubMed
41979099Hybrid Systems Modeling of Donor T-Cell Responses and Graft-Versus-Host-Disease After Posttransplantation Cyclophosphamide Administration.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/41979099PubMed
41811903CAR-Cell Therapy for Autoimmune Diseases: From the Laboratory to Clinical Practice.J Immunol Res2026https://conductscience.org/library/papers/41811903PubMed
41799211In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis.Theranostics2026https://conductscience.org/library/papers/41799211PubMed
41758930Regulatory-like FOXP3+Helios+CD4+ T conventional cells correlate with T-cell activation after Orca-T immunotherapy.Blood2026https://conductscience.org/library/papers/41758930PubMed
41550465Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation.MedComm (2020)2026https://conductscience.org/library/papers/41550465PubMed
41521559Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases.Mol Ther2026https://conductscience.org/library/papers/41521559PubMed
41459483Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell function.Front Immunol2025https://conductscience.org/library/papers/41459483PubMed
41411147Posttransplant cyclophosphamide in HLA-matched peripheral blood transplantation: what's next?Blood2026https://conductscience.org/library/papers/41411147PubMed
41385341Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial.Blood2026https://conductscience.org/library/papers/41385341PubMed
41252283Allogeneic haematopoietic cell transplantation promotes atherosclerosis in mice via CD8+ T cells.Cardiovasc Res2025https://conductscience.org/library/papers/41252283PubMed
41172558Regulatory T cell approaches for graft-versus-host disease prevention.Curr Opin Immunol2026https://conductscience.org/library/papers/41172558PubMed
40942043BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation.Molecules2025https://conductscience.org/library/papers/40942043PubMed

See all 605 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12925844

GET https://conductscience.org/api/papers/v1/12925844/cited_by?page=2